Page 75 - MEMORIA ANUAL 2019 SEHH-FEHH

Programa EsPañol dE TraTamiEnTos En HEmaTología (PETHEma)
MEMORIA ANUAL 2019
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
Dexamethasone Versus Clarythromycin, Lenalidomide and Dexamethasone As First Line Treatment in Patients with Multiple Myeloma Not Candidates for Au- tologous Stem Cell Transplantation: Results of the GEM-Claridex Clinical Trial. 61st Annual Meeting of the ASH. Orlando, Dec 7-10, 2019. Blood. 2019;134(Supple- ment_1):694. https://doi.org/10.1182/blood-2019-123997.
• Puig N, Mateos MV, Contreras T, Paiva B, Cedena MT, Pérez JJ, Aires I, Agullo C, Martínez-López J, Rodríguez Otero P, González De La Calle V, González MS, Oriol A, Gutiérrez NC, Ríos R, Rosiñol L, Álvarez MA, Calasanz MJ, Bargay J, González AP, Alegre A, Escalante F, Martínez R, de la Rubia J, Teruel AI, De Arriba F, Palomera L, Hernández MT, López J, Martín J, García Mateo A, García-Sanz R, Ocio EM, Bla- dé J, Lahuerta JJ, San-Miguel JF. Qip-Mass Spectrometry in High Risk Smolder- ing Multiple Myeloma Patients Included in the GEM-CESAR Trial: Comparison with Conventional and Minimal Residual Disease IMWG Response Assessment. 61st Annual Meeting of the ASH. Orlando, Dec 7-10, 2019. Blood. 2019;134(Supple- ment_1):581. https://doi.org/10.1182/blood-2019-127717.
• Rodríguez S, Puig N, Gemenetzi K, Goicoechea I, Botta C, Agathangelidis A, Val- dés-Mas R, Garcés JJ, Cedena MT, Pérez JJ, Burgos L, Calasanz MJ, Alignani D, Vilas-Zornoza A, Lorenzo-Vivas E, Aires I, Rodríguez I, Sarvide S, Prosper F, Martínez- Climent JA, Orfao A, García-Sanz R, Martínez-López J, Lahuerta JJ, Rosinol Dachs L, Bladé J, Mateos MV, Hadzidimitriou A, San-Miguel J, Paiva B. The Pathogen- esis of Multiple Myeloma (MM) Is Preceded By Mutated Lymphopoiesis and B Cell Oligoclonality That Persist in Patients with Negative Minimal Residual Disease (MRD). 61st Annual Meeting of the ASH. Orlando, Dec 7-10, 2019. Blood. 2019;134(Supplement_1):509. https://doi.org/10.1182/blood-2019-128049.
• Costa LJ, Iacobelli S, Pasquini MC, Modi R, Giaccone L, Bladé J, Schonland S, Evan- gelista A, Pérez-Simón JA, Hari P, Brown EE, Giralt SA, Patriarca F, Stadtmauer EA, Rosinol L, Krishnan AY, Gahrton G, Bruno B. Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up. 61st Annual Meeting of the ASH. Orlando, FL, Dec 07-10, 2019. Blood. 2019;134(Supple- ment_1):259. https://doi.org/10.1182/blood-2019-121367.
• Ramos F, Martínez-Cuadrón D, Serrano J, López-Pavia M, Fuertes-Núñez M, Ber- nal T, Rodríguez-Gutiérrez JI, Recio I, Garrido A, García D, Sossa CL, Gil C, Varela R, Martínez-Sánchez P, Foncillas MA, Tormo M, Cladera A, Esteves G, Falantes JF, de la Fuente A, Boluda B, Sanz MA, Montesinos Fernández P. A Predictive Model for
75